NAD+ Mounjaro Stack — Metabolic Enhancement Protocol

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Cellular energy metabolism and hormonal regulation work in tandem to determine how your body processes nutrients and maintains weight. A growing body of research suggests that combining NAD+ precursors with GLP-1 receptor agonists like tirzepatide may amplify metabolic efficiency by targeting mitochondrial function alongside appetite and glucose control.

How NAD+ and Tirzepatide Work Together for Metabolic Function

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for cellular energy production, DNA repair, and metabolic enzyme activation. Tirzepatide works as a dual GLP-1 and GIP receptor agonist, signaling your body to regulate blood sugar and reduce hunger signals. When combined thoughtfully, these compounds may support energy availability at the cellular level while the tirzepatide component manages glucose metabolism and appetite—creating a more complete metabolic environment for sustainable weight management.

The theoretical advantage of stacking NAD+ with tirzepatide lies in addressing multiple biological systems: mitochondrial function improves when NAD+ levels rise, while tirzepatide simultaneously reduces caloric intake and improves insulin sensitivity. This dual mechanism may help prevent the energy slump some patients experience during weight loss, as adequate NAD+ supports the conversion of nutrients into ATP (cellular energy). Neither compound directly causes the other to work better, but optimizing both pathways may create more favorable metabolic conditions.

NAD+ Precursors and Metabolic Pathways in Weight Management

NAD+ is synthesized from dietary precursors including nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and standard niacin. As humans age, NAD+ production naturally declines, which correlates with reduced mitochondrial efficiency and slower metabolic rate. Restoring NAD+ levels may support sirtuin activation—a family of enzymes that regulate cellular stress responses, longevity pathways, and fat oxidation. Some research suggests that elevated NAD+ can enhance the metabolic benefit of caloric restriction by preserving metabolic flexibility during weight loss phases.

Tirzepatide complements NAD+ support by directly addressing appetite and insulin dynamics through GLP-1 and GIP signaling. In clinical trials, tirzepatide demonstrated superior weight loss compared to semaglutide alone, with some patients achieving 20% or greater body weight reduction. When NAD+ levels are optimized alongside this hormonal support, the combination may promote fat oxidation while preserving lean muscle mass—a critical goal during any metabolic intervention.

Precision Peptide Genetic Testing and Personalized NAD+ Response

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic predisposition to NAD+ metabolism helps explain why some patients achieve robust metabolic improvements with tirzepatide alone, while others may benefit from additional NAD+ support. PlexusDx uses this genetic data to identify which metabolic bottlenecks are most limiting in your specific case, enabling a truly personalized approach to the NAD+ and tirzepatide stack rather than a one-size-fits-all protocol.

PlexusDx Tirzepatide Injection and Metabolic Support Accessibility

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) and is delivered from licensed 503A compounding pharmacies across all 50 states without requiring insurance or membership fees. The pricing model ensures that your dose may need to go up as your body responds to treatment, but your price won't change—a key distinction from traditional flat per-compound pricing structures. HSA and FSA accounts are eligible for use with PlexusDx tirzepatide, reducing out-of-pocket costs for many patients seeking metabolic optimization.

When considering a NAD+ and tirzepatide protocol, PlexusDx provides the foundational GLP-1/GIP therapy with high-quality compounded tirzepatide, while patients can source NAD+ precursors through supplements and consultation with their healthcare provider. This separation of pharmaceutical-grade peptide therapy from over-the-counter NAD+ support allows flexibility in personalizing the full stack to individual preferences and budget constraints. The Precision Peptide Genetic Test helps confirm whether NAD+ augmentation aligns with your genetic risk factors for metabolic dysfunction.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is a NAD+ and tirzepatide stack, and why would I consider it?

A NAD+ stack with tirzepatide combines cellular energy support (via NAD+ precursors) with hormonal appetite and glucose regulation (via tirzepatide). Some patients pursue this combination to address both mitochondrial fatigue during weight loss and maintain steady energy levels. PlexusDx provides the clinical-grade tirzepatide injection ($289/month) while patients source NAD+ supplements separately in consultation with their provider.

Is there clinical evidence that NAD+ and tirzepatide work better together?

While tirzepatide's efficacy is well-established in clinical trials showing 20%+ weight loss, formal studies specifically combining NAD+ precursors with tirzepatide are emerging. Both compounds have independent metabolic benefits—tirzepatide reduces appetite and improves insulin sensitivity, while NAD+ supports mitochondrial function and cellular stress pathways. The stacking approach is based on complementary mechanisms rather than synergy data, and should be discussed with your healthcare provider.

How much does PlexusDx tirzepatide cost, and is it covered by insurance?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with a flat-rate pricing model—your dose may increase, but your monthly price won't. No insurance is required, and the medication is available across all 50 states. HSA and FSA accounts are eligible, which can offset costs for many patients.

Are there safety concerns with combining NAD+ supplements and tirzepatide?

Tirzepatide is a well-tolerated GLP-1/GIP agonist with established safety data, while NAD+ precursors are generally recognized as safe dietary supplements. No major contraindications exist between the two classes, though patients should inform their healthcare provider about all supplements and medications. GI side effects from tirzepatide may temporarily reduce nutrient absorption, so timing NAD+ supplementation away from meals and tirzepatide doses can optimize absorption.

Can the Precision Peptide Genetic Test help determine if I need NAD+ support?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 after first treatment month) analyzes 14 metabolic pathways and 150+ genetic insights, including variants affecting NAD+ biosynthesis and mitochondrial enzyme function. If your genetic profile indicates reduced NAD+ sufficiency or impaired sirtuin pathway activation, this data supports the case for NAD+ precursor supplementation alongside your tirzepatide therapy.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.